Clinical Trial Update: A Study of Tucatinib and Trastuzumab in People With Rectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of tucatinib and trastuzumab in rectal cancer patients is currently recruiting, including HER2-positive case…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Adenocarcinoma
• Rectal Cancer

Drugs mentioned

• Trastuzumab (trastuzumab)
• Tucatinib (tucatinib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Adenocarcinoma of the Rectum, Locally Advanced Rectal Adenocarcinoma | Phase 2 | Status: RECRUITING